Key Takeaways
- Ketamine therapy can offer rapid relief within hours for treatment resistant depression,
- Ketamine has been used to treat 10+ mental health conditions including PTSD, bipolar disorder, and chronic pain, compared to TMS’s primary focus on depression and OCD
- TMS has better insurance coverage but ketamine provides faster symptom relief for urgent cases
- Both treatments have excellent safety profiles, with ketamine and TMS showing significant response rates
- Combined therapy protocols are emerging as potentially superior to either treatment alone but require further research
Understanding Ketamine and TMS: Revolutionary Mental Health Treatments
Traditional antidepressant medications may fail to help a large number of clients with major depressive disorder, leaving millions struggling with persistent depression symptoms despite trying multiple treatments. This sobering reality has driven the development of innovative depression treatments that target different neural pathways than conventional approaches.
Two groundbreaking treatments have emerged as game-changers in mental health treatment: ketamine therapy and Transcranial M agnetic S timulation(TMS). Ketamine, originally developed as an anesthetic, received FDA approved status in 2019 through the esketamine nasal spray formulation (Spravato) for treatment resistant depression. Transcranial Magnetic Stimulation gained FDA approval in 2008 as a non-invasive brain stimulation technique for major depression.
These innovative treatments represent a paradigm shift in mental healthcare, offering hope to depressed clients who haven’t responded to traditional antidepressant medications. Unlike conventional approaches that rely on altering brain chemistry through daily medication, both ketamine and TMS directly influence brain function through targeted mechanisms that promote neuroplasticity and improve depression symptoms.
How Ketamine Therapy Works
Ketamine treatment operates through a fundamentally different mechanism than traditional medications. Rather than targeting serotonin or dopamine pathways like conventional antidepressants, ketamine acts as an NMDA receptor antagonist, blocking glutamate receptors in the brain. This blocking action triggers a cascade of neurobiological changes that promote rapid symptom relief.
The treatment’s effectiveness lies in its ability to enhance neuroplasticity within 24 hours of administration. Ketamine increases brain-derived neurotrophic factor (BDNF), a protein that promotes the growth and survival of nerve cells. This neuroplasticity enhancement allows the brain to form new neural connections and break free from the dysfunctional thought patterns characteristic of depression and other mood disorders.
Ketamine is administered through two primary methods: IV ketamine infusions and the esketamine nasal spray. IV infusions typically involve sessions lasting 60-90 minutes, while the nasal spray requires administration under medical supervision at certified clinics for a minimum of 120 minutes. Most clients follow a typical treatment protocol of 6 ketamine infusions over 2-3 weeks, though some may need additional sessions based on their response.
Ketamine’s Mechanism of Action
The blocking of glutamate receptors creates what researchers call a “reset” of neural pathways that have become dysfunctional in mental health disorders. Unlike traditional antidepressants that require weeks to build therapeutic levels, ketamine’s rapid antidepressant effects can become apparent within 2-4 hours post-treatment.
This mechanism promotes synaptic growth and enhances brain connectivity, particularly in regions like the prefrontal cortex that are often impaired in severe depression. Clinical trials have consistently demonstrated that ketamine can relieve depression symptoms even in clients who haven’t responded to multiple other treatments.
Related article: How to Know If Ketamine Is Working: Signs and Indicators of Treatment Success
How Transcranial Magnetic Stimulation (TMS) Works
TMS therapy uses electromagnetic technology to stimulate specific brain regions associated with mood regulation. The treatment involves placing an electromagnetic coil against the scalp, typically targeting the dorsolateral prefrontal cortex (DLPFC), an area that shows decreased activity in most clients with depression. This coil applies magnetic pulses to stimulate nerve cells in the targeted region.
The repetitive transcranial magnetic stimulation device delivers magnetic pulses that penetrate approximately 2-3 centimeters into brain tissue. These magnetic pulses stimulate nerve cells in the targeted region, gradually increasing neural activity and promoting brain function improvements over time. Unlike electroconvulsive therapy (ect), TMS treatment requires no anesthesia and allows clients to remain fully conscious throughout sessions.
A typical TMS treatment course consists of approximately 30 daily sessions lasting from 20-40 minutes each. TMS sessions are delivered over 6 weeks. TMS typically requires multiple sessions over several weeks to achieve significant improvements in depressive symptoms. The gradual nature of TMS therapy means that symptom reduction typically becomes noticeable after weeks of consistent treatment.
TMS Treatment Process
The treatment process begins with brain mapping to determine the precise location for coil placement. Technicians use motor threshold determination to calibrate the magnetic pulse intensity for each individual client, ensuring optimal treatment outcomes while minimizing side effects like mild scalp discomfort.
The gradual neuroplasticity changes induced by repetitive magnetic pulses help restore normal function to underactive brain regions. This approach to brain stimulation offers a non-invasive alternative to more intensive procedures while providing sustained symptom relief for many clients.
Treatment Comparison Table
| Aspect | Ketamine | TMS |
| Speed of Relief | 2-4 hours | 2-4 weeks |
| Treatment Duration | 6 sessions over 2-3 weeks | 30 sessions over 6 weeks |
| FDA Approval | 2019 (Spravato for TRD) | 2008 (Depression) |
| Response Rate | 70% | 50-60% |
| Maintenance Required | Yes (monthly sessions) | Minimal |
| Insurance Coverage | 30-40% | 80-90% |
| Average Cost | $400-800 per session | $300-500 per session |
| Side Effects | Dissociation, nausea, blood pressure changes | Mild headache, scalp discomfort |
| Conditions Treated | 10+ mental health conditions | Primarily depression, OCD |
| Consciousness Level | Altered during treatment | Fully alert |
Mental Health Conditions: Which Treatment Works Best
Both treatments offer significant benefits, but their effectiveness varies depending on the specific mental health conditions being treated. Understanding which treatment works best for different scenarios is crucial for optimal client outcomes.
The personalized treatment approach requires careful consideration of symptom severity, urgency of relief needed, and individual client factors. While both treatments can improve depression symptoms, their mechanisms and condition coverage differ substantially.
Conditions Best Treated with Ketamine
Ketamine demonstrates exceptional versatility in treating multiple mental health disorders simultaneously. The treatment’s rapid action and broad neurobiological effects make it particularly effective for complex cases involving multiple comorbid conditions.
Treatment-resistant depression represents ketamine’s strongest indication, with clinical trials showing 70% response rates even in clients who failed multiple traditional antidepressant medications. The rapid symptom relief makes ketamine invaluable for clients experiencing severe symptoms that interfere with daily functioning.
Suicidal ideation responds remarkably well to ketamine treatment, with many clients experiencing rapid reduction in suicidal thoughts within 24 hours. This rapid response can be life-saving for clients in crisis situations where traditional medications would take weeks to achieve therapeutic effects.
Bipolar disorder, particularly treatment-resistant bipolar depression, shows excellent response to ketamine therapy. The treatment helps stabilize mood fluctuations and provides relief from depressive episodes that haven’t responded to mood stabilizers or antidepressants.
PTSD with trauma-related symptoms benefits significantly from ketamine’s ability to disrupt traumatic memory consolidation and reduce hypervigilance. Veterans and trauma survivors often experience substantial improvement in flashbacks, nightmares, and emotional numbing. Ketamine therapy is also being explored for other conditions, such as Complex Regional Pain Syndrome (CRPS), offering hope for those seeking alternative pain relief solutions.
Chronic pain syndromes including fibromyalgia and neuropathic pain respond well to ketamine due to its action on pain pathways. Many clients experience simultaneous relief from both chronic depression and chronic pain conditions.
Obsessive compulsive disorder shows promising results with ketamine treatment, particularly in cases where traditional serotonin reuptake inhibitors haven’t provided adequate relief from obsessive thoughts and compulsive behaviors.
Anxiety disorders with severe symptoms often respond rapidly to ketamine, especially when anxiety co-occurs with depression. The treatment can break the cycle of anxious rumination that maintains both conditions.
Eating disorders including anorexia and bulimia show emerging evidence for ketamine effectiveness, particularly when these conditions co-occur with severe depression or trauma history.
Substance abuse disorders benefit from ketamine’s ability to reduce cravings and break addictive thought patterns, though this requires specialized protocols and careful monitoring.
Postpartum depression responds exceptionally well to ketamine, offering rapid relief that allows new mothers to bond with their infants and function effectively during this critical period.
Related article: Your First Ketamine Session: A Step-by-Step Guide to What Happens and How to Prepare
Conditions Best Treated with TMS
Tms therapy demonstrates strong efficacy for specific conditions where its targeted brain stimulation approach proves most beneficial. The treatment’s precision in targeting specific brain regions makes it ideal for conditions with well-defined neural circuits.
Major depressive disorder represents TMS therapy’s primary FDA approved indication, with extensive clinical trial data supporting its effectiveness. The treatment works particularly well for clients who can tolerate the extended treatment timeline and prefer non-medication approaches.
Obsessive compulsive disorder received FDA approval for TMS treatment in 2018, with specialized coil positioning targeting the anterior cingulate cortex. This indication demonstrates TMS therapy’s expanding applications beyond depression treatment.
Smoking cessation gained FDA approval in 2020, representing an innovative application of brain stimulation technology. The treatment targets brain regions associated with addiction and craving reduction.
Migraine prevention shows limited but promising evidence for TMS effectiveness, though this remains an off-label application requiring further research to establish optimal protocols.
Choosing the Right Treatment Clinic: Essential Considerations
Selecting the appropriate clinic for ketamine vs TMS treatment requires careful evaluation of multiple factors that directly impact treatment outcomes and client safety. The quality of medical oversight and clinic protocols can significantly influence both the effectiveness and safety of these innovative treatments.
Board-certified psychiatrists and medical supervision represent non-negotiable requirements for both ketamine infusions and TMS sessions. Mental health treatments require specialized expertise in psychiatric medications, drug interactions, and emergency protocols. Clinics should maintain comprehensive medical oversight throughout the entire treatment process.
Clinic accreditation and safety protocols demonstrate commitment to maintaining the highest standards of client care. Look for facilities that follow established guidelines for ketamine dose administration and TMS therapy protocols. Proper emergency equipment and trained medical staff should be readily available during all treatment sessions.
Comprehensive mental health assessment processes ensure that treatment plans are tailored to individual client needs. Quality clinics conduct thorough evaluations, review medication history, and assess for contraindications before recommending either ketamine treatment or TMS therapy.
Integration with psychotherapy and medication management maximizes treatment outcomes for most clients. Clinics that coordinate care with therapists and psychiatrists provide more comprehensive mental health treatment than those offering isolated interventions.
Treatment customization based on individual needs recognizes that ketamine vs TMS decisions should consider factors like symptom severity, treatment history, and personal preferences. The best clinics offer both treatment options and can guide clients toward the most appropriate choice.
The Wellness Drip, Inc. in West Springfield, Massachusetts exemplifies premier ketamine treatment delivery with comprehensive medical oversight and personalized treatment protocols. Their approach integrates medical supervision with individualized ketamine dose optimization to maximize client outcomes while ensuring safety.
Side Effects and Safety Profiles
Both ketamine and TMS therapy demonstrate excellent safety profiles when administered under proper medical supervision. Understanding the side effect profiles helps clients make informed decisions and prepare appropriately for treatment.
Comprehensive client screening eliminates individuals with contraindications and ensures that only appropriate candidates receive treatment. Both treatments require thorough medical evaluation before initiation.
Ketamine Side Effects
Ketamine therapy’s side effects are generally short-term, resolving completely within 2 hours of treatment completion. Most clients tolerate the treatment well, though some individuals may find the temporary effects challenging. Common short-term side effects of ketamine include disorientation, loss of motor coordination, dizziness, nausea, and increased blood pressure.
Common short-term effects include dissociation or altered perception during the infusion period. Clients may feel detached from their environment or experience mild perceptual changes. These effects are temporary and typically resolve within 60-90 minutes post-treatment.
Nausea may occur for some clients, but is usually mild and manageable with anti-nausea medications. Dizziness may accompany nausea, but resolves as the ketamine effects diminish.
Blood pressure elevation during treatment is common and expected, requiring monitoring throughout the session. Clients with pre-existing hypertension need careful evaluation and monitoring, though most can safely receive treatment. At The Wellness Drip, continuous vital monitoring with state-of-the-art technology assists in accurate and consistent vital sign monitoring, taking safety a step further.
Long-term risks seen in chronic recreational ketamine use, such as urinary tract or bladder issues and changes in cognition, have been documented in the context of frequent, high-dose, unsupervised use. These patterns differ significantly from controlled medical ketamine treatment, which uses lower, clinically guided dosing and structured monitoring. Clients should discuss any questions or concerns with their licensed medical provider to understand what is appropriate for their individual situation.
Safety in clinical settings with proper monitoring eliminates most risks associated with ketamine therapy. Professional administration ensures appropriate ketamine dose and immediate medical intervention if needed.
TMS Side Effects
TMS therapy produces minimal side effects, making it well-tolerated by most clients. The non-invasive nature of magnetic stimulation results in fewer systemic effects compared to medications. Clients receiving TMS can return to their normal daily activities immediately after treatment, while ketamine requires monitoring for side effects post-treatment.
Mild scalp discomfort represents the most common side effect, occurring in a majority of clients during the first few TMS sessions. This discomfort typically diminishes as clients become accustomed to the treatment sensation.
Mild headache affects a number of clients, but are usually mild and responsive to over-the-counter pain medications. These headaches typically decrease in frequency and intensity as treatment progresses.
Facial muscle twitching during treatment occurs due to magnetic stimulation of nearby muscle groups. This effect is harmless and stops immediately when the magnetic pulses cease.
Seizures are a rare but recognized serious risk. Proper screening should eliminate clients with seizure risk factors.
Real Client Success Stories: Ketamine Treatment Outcomes
Real-world client experiences demonstrate ketamine therapy’s transformative potential across diverse mental health conditions. These success stories illustrate the rapid and sustained improvements possible with proper ketamine treatment protocols.
Case Study 1: Executive with Treatment-Resistant Depression
Sarah, a 45-year-old corporate executive, had struggled with severe depression for over a decade despite trying eight different antidepressant medications. Her depressive symptoms included overwhelming fatigue, inability to concentrate at work, and persistent hopelessness that interfered with her leadership responsibilities.
After six ketamine sessions over three weeks, Sarah experienced complete remission of her depression symptoms. Her energy levels normalized, concentration returned, and she regained enthusiasm for both work and personal relationships. Maintenance ketamine infusions every 6-8 weeks have sustained her improvement for over two years.
Case Study 2: Military Veteran with PTSD
Mark, a 38-year-old Army veteran, experienced severe PTSD symptoms following multiple combat deployments. His symptoms included debilitating flashbacks, nightmares, hypervigilance, and social isolation that prevented him from maintaining employment or relationships.
Ketamine treatment produced a significant reduction in PTSD symptoms within the first month. Mark’s flashbacks decreased dramatically, sleep quality improved significantly, and he successfully returned to work. The treatment allowed him to engage effectively in talk therapy for the first time since his military service ended.
Case Study 3: Chronic Pain Client with Depression
Jennifer, a 52-year-old nurse, developed chronic fibromyalgia pain that led to severe depression and forced medical retirement. Traditional pain medications provided minimal relief, and antidepressants worsened her fatigue without improving mood.
Ketamine treatment addressed both her chronic pain and depression simultaneously. Her pain levels decreased dramatically, depression lifted, and she returned to part-time nursing work. The dual benefits of ketamine for both conditions transformed her quality of life.
Case Study 4: Postpartum Depression Recovery
Lisa, a 29-year-old new mother, developed severe postpartum depression that prevented bonding with her newborn. Traditional antidepressants were contraindicated due to breastfeeding, leaving her with limited treatment options during this critical period.
Rapid ketamine treatment enabled Lisa to bond with her baby within days of starting therapy. Her maternal instincts returned, sleep improved despite night feedings, and she experienced joy in motherhood for the first time. This early intervention prevented long-term bonding difficulties.
Long-term follow-up data across all cases shows sustained improvement with appropriate maintenance sessions. Most clients maintain significant symptom reduction with maintenance ketamine infusions, demonstrating the treatment’s durability when properly managed.
Cost Analysis and Insurance Coverage
Understanding the financial aspects of ketamine vs TMS therapy helps clients plan for treatment and explore available options. Cost considerations often influence treatment decisions, making insurance coverage and payment options crucial factors.
Ketamine treatment costs typically range from $400-800 per session, with most clients requiring 6-8 initial sessions for optimal results. The total initial treatment cost ranges from $2,400 and up, fluctuating significantly with different regions.
TMS therapy costs $6,000-15,000 for a complete treatment course, though the total cost is often spread across 30 sessions over six weeks.
Payment plans and financing options are available at many clinics to address out-of-pocket expenses. The Wellness Drip accepts AfterPay and Care Credit. They can also generate a “super bill” for you to submit to insurance for potential reimbursement. Long-term cost comparison must consider maintenance treatment requirements. While ketamine may require maintenance sessions, TMS may need periodic “booster” treatments if symptoms return, affecting the total cost of care over time.
Emerging Combined Treatment Approaches
Research into simultaneous ketamine and TMS protocols represents an exciting frontier in mental health treatment. Early studies suggest that combining these two innovative treatments may produce superior outcomes compared to either therapy alone.
The rationale for combination therapy lies in the complementary mechanisms of action. Ketamine’s rapid NMDA receptor modulation combined with TMS therapy’s targeted electromagnetic stimulation may enhance neuroplasticity synergistically, possibly leading to more robust and sustained improvements.
Early clinical trial results show promising enhanced outcomes in clients receiving combined treatment. Preliminary data suggests that clients may achieve higher response rates and longer-lasting symptom relief when both treatments are used strategically together.
Potential synergistic effects on neuroplasticity make biological sense, as ketamine enhances the brain’s capacity for change while TMS provides targeted stimulation to specific brain regions. This combination may maximize the brain’s ability to form new neural pathways associated with improved mood and function. Research is still in its early stages
Future directions in combination therapy include optimized timing protocols, determining the ideal sequence of treatments, and identifying which clients benefit most from combined approaches. Research continues to refine these protocols for maximum effectiveness.
Making Your Treatment Decision
Choosing between ketamine vs TMS requires careful consideration of multiple factors specific to your individual situation. The decision should be made collaboratively with qualified healthcare providers who understand your complete medical and psychiatric history.
Urgency of symptoms represents a critical factor in treatment selection. Clients experiencing suicidal ideation or severe symptoms requiring rapid relief may benefit more from ketamine’s fast-acting properties, while those who can tolerate a gradual improvement timeline may find TMS therapy appropriate.
Treatment history influences which option is likely to be most effective. clients who haven’t responded to multiple medication trials may be excellent candidates for either treatment, though ketamine’s broader mechanism of action may offer advantages for complex cases.
Lifestyle considerations affect treatment feasibility. TMS therapy requires daily clinic visits for six weeks, which may be challenging for some clients. Ketamine treatment requires fewer sessions but involves temporary and mild consciousness alteration that some clients find concerning.
Questions to ask your healthcare provider include:
- Which treatment is most appropriate for my specific symptoms?
- What are the expected timelines for improvement?
- How do these treatments interact with my current medications?
- What are the long-term maintenance requirements?
- Which treatment does my insurance plan cover?
Timeline expectations should be realistic for both treatments. Ketamine provides rapid symptom relief but may require ongoing maintenance, while TMS therapy takes longer to show effects but may require maintenance.
Comprehensive evaluation remains essential regardless of which treatment is chosen. Both therapies work best when integrated into a complete mental health treatment plan that may include psychotherapy, medication management, and lifestyle modifications.
Summary and Treatment Recommendations
The comparison between ketamine vs TMS reveals two powerful but distinct approaches to treating mental health disorders. Each treatment offers unique advantages that make them suitable for different client populations and clinical scenarios.
Ketamine advantages include rapid symptom relief, sometimes within hours, effectiveness across 10+ mental health conditions, and may be particularly helpful with urgent cases involving suicidal ideation. The treatment’s broad neurobiological effects make it invaluable for complex cases with multiple comorbid conditions.
TMS therapy advantages include established insurance coverage, minimal side effects, and no consciousness alteration during treatment. The treatment’s precision in targeting specific brain regions makes it ideal for clients seeking a non-invasive approach with predictable effects.
Combination therapy represents an emerging gold standard that may offer superior outcomes for carefully selected clients. The synergistic effects of both treatments working together may maximize neuroplasticity and provide more comprehensive symptom relief. More research is needed.
The importance of individualized treatment selection cannot be overstated. The best treatment choice depends on factors including symptom severity, urgency of relief needed, lifestyle considerations, and personal preferences regarding treatment approach.
The Wellness Drip, Inc. in West Springfield, Massachusetts exemplifies comprehensive ketamine care with their integrated approach to mental health treatment. Their expertise in ketamine therapy protocols and commitment to client safety makes them an excellent example of quality mental health treatment delivery.
Both treatments represent significant advances over traditional approaches and offer hope to clients who haven’t found relief with conventional therapies. The continued refinement of protocols and emergence of combination approaches promise even better outcomes for future clients.
Further Reading and Resources
American Psychiatric Association. (2019). Practice guideline for the treatment of clients with major depressive disorder (3rd ed.). American Journal of Psychiatry, 176(4), 290-327.
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., … & Downar, J. (2018). Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in clients with depression (THREE-D): A randomised non-inferiority trial. The Lancet, 391(10131), 1683-1692.
Conway, C. R., George, M. S., & Sackeim, H. A. (2018). SNI: Neurostimulation for treatment-resistant depression. Surgical Neurology International, 9, 67.
Daly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., … & Drevets, W. C. (2018). Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry, 75(2), 139-148.
Dębowska, W., Nowaczyk, M., & Głąbiński, A. (2023). Transcranial magnetic stimulation and ketamine: Implications for combined treatment in depression. Frontiers in Neuroscience, 17, 1163625. https://doi.org/10.3389/fnins.2023.1163625
Kraus, C., Wasserman, D., Henter, I. D., Acevedo-Diaz, E., Kadriu, B., & Zarate Jr, C. A. (2019). The influence of ketamine on drug discovery in depression. Drug Discovery Today, 24(10), 2033-2043.
Mikellides, G., Pantelidou, E., Michael, P., Polycarpou, M., & Tantele, M. (2022). A retrospective naturalistic study comparing the efficacy of ketamine and repetitive transcranial magnetic stimulation for treatment-resistant depression. Frontiers in Psychiatry, 13, 900595.https://doi.org/10.3389/fpsyt.2022.900595
Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation, 9(3), 336-346.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856–864.https://doi.org/10.1001/archpsyc.63.8.856
Frequently Asked Questions
How quickly does ketamine work compared to TMS for severe depression?
Ketamine can offer quick symptom relief in just 2 to 4 hours after treatment. Many clients notice significant improvement within 24 hours. TMS therapy requires 2-4 weeks of daily treatment before noticeable symptom reduction occurs. For clients with severe depression or suicidal ideation, ketamine’s rapid action may be a preferred choice.
Can I receive both ketamine and TMS treatments simultaneously?
Yes, emerging research supports combined ketamine and TMS protocols for enhanced treatment outcomes. Some clinics offer coordinated treatment plans that strategically combine both therapies to maximize neuroplasticity and symptom improvement. However, combined treatment requires careful medical supervision and may not be appropriate for all clients. Discuss this option with a qualified psychiatrist experienced in both treatments.
What happens if neither ketamine nor TMS works for my condition?
While both treatments show high success rates, some clients may not respond adequately to either therapy alone. Alternative options include trying the other treatment if only one was attempted, exploring combination therapy approaches, or considering other innovative treatments like electroconvulsive therapy. Your psychiatrist may also recommend adjusting current medications or exploring intensive psychotherapy approaches. Non-response to one treatment doesn’t predict failure with another.
Are there age restrictions for ketamine or TMS therapy?
TMS therapy is FDA-approved for adults and has been studied in adolescents under certain circumstances. Most clinics accept clients 18 years and older for TMS treatment. Ketamine treatment typically requires clients to be at least 18 years old for IV infusions, while Spravato nasal spray is approved for adults only. Upper age limits are generally not imposed if clients are medically stable, though elderly clients may require additional medical screening.
How do I know if my insurance will cover these treatments?
TMS therapy has higher insurance approval rates due to established FDA approval, but requires prior authorization and documentation of treatment-resistant depression. Contact your insurance provider to verify coverage and obtain pre-authorization requirements. Ketamine coverage is more limited with most insurers covering only Spravato nasal spray rather than IV ketamine.
